MedTrace Logo

A Study of the GRIP Influenza and SARS-CoV-2 POC Assays

NCT05674370 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2024-03-21

Study results available
· View outcomes & findings →

Summary

The purpose of this research is to determine if the use of a new device can accurately detect a virus infection.

Conditions

Interventions

DEVICE

GRIP Electronic Diagnostic Chip

Graphene-based point-of-care device for detection of respiratory viruses (e.g., COVID-19 and influenza) from a nasal swab

DIAGNOSTIC_TEST

Laboratory-based nucleic acid amplification tests (NAATs)

Polymerase Chain Reaction (PCR) analysis for detection of viruses (e.g., Roche cobas SARS-CoV-2 or influenza A/B) from nasal swab

Sponsors & Collaborators

Principal Investigators

  • Matthew Binnicker, PhD · Mayo Clinic

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2023-04-30
Completion
2023-04-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05674370 on ClinicalTrials.gov